253P Risk factor (RF) identification (ID) and hyperglycemia (HG) prevention with alpelisib (ALP) + fulvestrant (FLV) in PIK3CA-mutated, hormone-receptor positive (HR+), human epidermal growth factor-2 negative (HER2-) advanced breast cancer (ABC)
| Autor: | Burnette, S., Poehlein, E., Lee, H-J., Force, J., Westbrook, K., Moore, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S470-S470 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|